NCT01247272View on ClinicalTrials.gov

90 mg Fluoxetine Hydrochloride Capsules Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

May 31, 2001

Primary Completion Date

July 31, 2001

Study Completion Date

July 31, 2001

Conditions
Healthy
Interventions
DRUG

Fluoxetine Hydrochloride

90 mg Capsules

DRUG

PROZAC WEEKLY®

90 mg Capsules

Trial Locations (1)

58102

PRACS Institute, Ltd., Fargo

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT01247272 - 90 mg Fluoxetine Hydrochloride Capsules Under Fasting Conditions | Biotech Hunter | Biotech Hunter